Patients with chronic hepatitis C virus infection and type 2 diabetes had a nearly twofold increased risk of developing hepatocellular carcinoma and other malignancies including pancreatic and gastric cancers following interferon therapy, a study showed. However, maintaining mean A1C levels of less than 7.0% was associated with lower HCC risk, researchers reported in the journal Hepatology.

Related Summaries